# Commission Implementing Regulation (EU) 2016/1085 of 5 July 2016 approving Bacillus amyloliquefaciens strain ISB06 as an existing active substance for use in biocidal products of product-type 3 (Text with EEA relevance), Article 1

Extent: E+W+S+N.I.

Bacillus amyloliquefaciens strain ISB06 is approved as an active substance for use in biocidal products of product-type 3, subject to the conditions set out in the Annex.

---
Source: https://www.legislation.gov.uk/eur/2016/1085/article/1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2016-1085/article-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.